Universal Starch (524408)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low headline P/E of 8.88 with book value of ₹143.11 per share.
• Latest quarter shows positive net profit of ₹5 Cr on sales of ₹118 Cr.
• ROE of 10.76% is respectable for a small-cap agricultural processor.
• Price is at its 52-week high, reflecting some market confidence.

Concerns

• Sales declined 8.47% and profits declined 25.36%, showing a deteriorating earnings trend.
• Piotroski F-Score of 3/9 points to weak financial health.
• No dividend means zero income while waiting for a turnaround.
• Current price of ₹215.20 is the 52-week high, offering little margin of safety despite falling fundamentals.

AI Analysis

Let's look at Universal Starch as a business, not a ticker. A ₹95 crore market cap, a P/E of 8.88 and a price of ₹215 against book value of ₹143.11. The valuation looks reasonable only if earnings are stable or growing. They are not. Sales fell 8.47% and profits fell 25.36%. The latest quarter did show ₹118 Cr of sales and ₹5 Cr of net profit, so the business is not broken, but the trend is moving in the wrong direction. The Piotroski F-Score of 3 out of 9 is a red flag; it suggests deteriorating financial health, not quiet strength. With ROE at 10.76% and ROCE at 9.43%, Universal earns a modest return on capital, but not enough to suggest a durable moat. In a commodity-like agricultural products business, pricing power is scarce; if input costs rise or starch prices soften, margins can compress quickly. And with zero dividend, I receive no income while I wait for a turnaround. Graham would insist on a margin of safety. Here, the stock sits at its 52-week high of ₹215.20 while earnings are declining. That is a poor combination. Buying a mediocre business at a cheap-looking multiple can still be a bad investment if the 'e' in the P/E is heading lower. If management can stabilize sales, protect margins, and improve the balance sheet, this could become interesting. But as of now, I see a slow, cyclical commodity business with weak fundamental signals. I would rather wait for a lower price, clearer signs of recovery, and better financial strength. Patience is the investor's greatest advantage.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer